WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹60 Cr | ₹1,072 Cr | ₹934 Cr | ₹889 Cr | ₹1,012 Cr |
What is the latest Contingent Liabilities ratio of WANBURY ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹60 Cr |
Mar2023 | ₹1,072 Cr |
Mar2022 | ₹934 Cr |
Mar2021 | ₹889 Cr |
Mar2020 | ₹1,012 Cr |
How is Contingent Liabilities of WANBURY Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹60 Cr | -94.40 | |
Mar2023 | ₹1,072 Cr | 14.78 | |
Mar2022 | ₹934 Cr | 5.01 | |
Mar2021 | ₹889 Cr | -12.14 | |
Mar2020 | ₹1,012 Cr | - |
Compare Contingent Liabilities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹921.4 Cr | -0.9% | 21.9% | 98.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹446,684.0 Cr | 2.9% | 6.4% | 48.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,935.0 Cr | 0.5% | -2.1% | 59.2% | Stock Analytics | |
CIPLA | ₹121,639.0 Cr | 2.3% | 1% | 20.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹115,931.0 Cr | 3.5% | 15.7% | 20.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,876.4 Cr | -0.1% | 2.3% | 41.1% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -0.9% |
21.9% |
98.3% |
SENSEX | -0.7% |
-1.6% |
11.1% |
You may also like the below Video Courses